CBOE Holdings Inc.

05/15/2019 | Press release | Distributed by Public on 05/15/2019 15:55

Verastem Oncology Highlights Will Present New COPIKTRA™ Dose Modification Data from Patients Treated in the Phase 3 DUO Study At ASCO

Cboe - Market News Story

Verastem Oncology Highlights Will Present New COPIKTRA™ Dose Modification Data from Patients Treated in the Phase 3 DUO Study At ASCO

Benzinga Newsdesk 5/15/2019 4:17:23 PM